Serpin b 13 as a marker for squamous cell carcinoma of the lung

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/574 (2006.01)

Patent

CA 2750001

The present invention relates to a method aiding in the assessment of squamous cell carcinoma (= SCC). It disclos-es the use of the protein serpin B13 as a marker of SCC. Furthermore, it relates to a method for assessing lung cancer in a tissue sample derived from a patient having non-small cell lung carcinoma (= NSCLC) and for differentiating SCC from adenocarcino-ma or large cell carcinoma of the lung.

La présente invention a pour objet un procédé favorisant l'évaluation d'un carcinome épidermoïde (= SCC). Elle concerne l'utilisation de la protéine serpine B13 en tant que marqueur du SCC. En outre, elle concerne un procédé d'évaluation du cancer du poumon dans un échantillon de tissu issu d'un patient souffrant d'un carcinome du poumon non à petites cellules (= NSCLC) et de différenciation du SCC de l'adénocarcinome ou du carcinome du poumon à grandes cellules.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Serpin b 13 as a marker for squamous cell carcinoma of the lung does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Serpin b 13 as a marker for squamous cell carcinoma of the lung, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serpin b 13 as a marker for squamous cell carcinoma of the lung will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1833771

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.